October 14, 2005

1/3 of LASIK Patients Unhappy With Results

Survey Finds More Than Two Million Americans Not Satisfied With Lasik Results

CHICAGO, Oct. 14 /PRNewswire/ -- Nearly 1 in 3 Americans have complained of under or over correction in one or both eyes, loss of quality of vision, vision fluctuations and poor vision in dark conditions, after undergoing Lasik surgery.

The survey conducted by Synovate and commissioned by NeuroVision Pte Ltd, also found that of all Americans who experience these conditions, those in the South and the mid-West, like Chicago, are more likely to have a second Lasik operation, compared with other regions.

"As Lasik is an invasive surgery performed on a very delicate part of the eye, potential problems may arise as a result of the operation," said Prof. Donald Tan, Director, Singapore Eye Research Institute, Deputy Director Singapore National Eye Centre. "Lasik has been an invaluable tool in vision correction, reducing refraction in patients by a significant percentage but it is not without its drawbacks."

1 in 3 respondents who encountered post-Lasik problems still wear their glasses or contacts and 1 in 7 of all respondents underwent a second Lasik operation. 

"In the past, there were few options to rectify unsatisfactory Lasik results. But now with the revolutionary NeuroVision treatment, patients can attain the sharp, crisp vision they desire," said Alain Leneveu, CEO, NeuroVision Pte. Ltd. "NeuroVision understands the intricacies of Lasik and is a complementary treatment to the surgery."

According to the survey, women are nearly three times more likely than men to undergo Lasik but men were more likely to complain and are twice as likely to be disappointed with their Lasik results complaining of over or under correction and poor night vision. 

"New data from NeuroVision, collated from over 300 international patients, has shown that post-Lasik patients, who have undergone NeuroVision, experienced a 2.6 lines improvement on the EDTRS chart and had a significant 100% enhancement in contrast sensitivity, moving their vision from the abnormal range to normal," said Prof. Donald Tan. "In total, 42% of both post-Lasik and low myopia patients improved by three lines or more on the EDTRS chart, with very minimal refraction changes."

NeuroVision is based on twenty years of scientific and clinical research, and is the world's first no surgery, no medication, no risk, vision treatment for low myopia, amblyopia and post-Lasik. 

The complete article is available at http://biz.yahoo.com/prnews/051014/nyf106.html?.v=11

Posted by Admin at October 14, 2005 05:23 PM